David G. Romero

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study.

Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study.

Journal: Archivos de bronconeumologia

Published: April 27, 2026

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Journal: Journal of investigational allergology & clinical immunology

Published: April 22, 2026

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use.

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use.

Journal: Biomedicines

Published: April 22, 2026

Long Term Effectiveness of Mepolizumab in the Treatment of Chronic Eosinophilic Pneumonia.

Long Term Effectiveness of Mepolizumab in the Treatment of Chronic Eosinophilic Pneumonia.

Journal: Open respiratory archives

Published: February 02, 2026

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Journal: Archivos de bronconeumologia

Published: December 30, 2025

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Journal: Respiration; international review of thoracic diseases

Published: October 01, 2025

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for tailored management.

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for tailored management.

Journal: Respiration; international review of thoracic diseases

Published: October 01, 2025

Eosinophil and Cationic Protein Levels in Patients Treated With Dupilumab: A Real-Life Study.

Eosinophil and Cationic Protein Levels in Patients Treated With Dupilumab: A Real-Life Study.

Journal: Open respiratory archives

Published: June 18, 2025

Mepolizumab as an Effective Alternative to Immunosuppressive and Teratogenic Therapies for the Early Treatment of EGPA: A Case Report.

Mepolizumab as an Effective Alternative to Immunosuppressive and Teratogenic Therapies for the Early Treatment of EGPA: A Case Report.

Journal: Journal of investigational allergology & clinical immunology

Published: May 29, 2025

Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved.

Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved.

Journal: Journal of clinical medicine

Published: May 29, 2025

Efficacy Assessment of Biological Treatments in Severe Asthma.

Efficacy Assessment of Biological Treatments in Severe Asthma.

Journal: Journal of clinical medicine

Published: October 29, 2024

Current Biologic Therapies for Severe Asthma and Real-World Data: Are Expectations Being Met?

Current Biologic Therapies for Severe Asthma and Real-World Data: Are Expectations Being Met?

Journal: Journal of clinical medicine

Published: October 28, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026